BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 34724334)

  • 21. Post-chemotherapy laparoscopic retroperitoneal lymph node dissection is feasible for stage IIA/B non-seminoma germ cell tumors.
    Nakamura T; Kawauchi A; Oishi M; Ueda T; Shiraishi T; Nakanishi H; Kamoi K; Naya Y; Hongo F; Okihara K; Miki T
    Int J Clin Oncol; 2016 Aug; 21(4):791-795. PubMed ID: 26701172
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Surgical Complications in Postchemotherapy Retroperitoneal Lymph Node Dissection for Nonseminoma Germ Cell Tumour: A Population-based Study from the Swedish Norwegian Testicular Cancer Group.
    Gerdtsson A; Håkansson U; Törnblom M; Jancke G; Negaard HFS; Glimelius I; Halvorsen D; Karlsdóttir Á; Haugnes HS; Andreassen KE; Larsen SM; Holmberg G; Wahlqvist R; Tandstad T; Cohn-Cedermark G; Ståhl O; Kjellman A
    Eur Urol Oncol; 2020 Jun; 3(3):382-389. PubMed ID: 31506250
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Surgery in Early Metastatic Seminoma: A Phase II Trial of Retroperitoneal Lymph Node Dissection for Testicular Seminoma With Limited Retroperitoneal Lymphadenopathy.
    Daneshmand S; Cary C; Masterson T; Einhorn L; Adra N; Boorjian SA; Kollmannsberger C; Schuckman A; So A; Black P; Bagrodia A; Skinner E; Alemozaffar M; Brand T; Eggener S; Pierorazio P; Stratton K; Nappi L; Nichols C; Luo C; Li M; Hu B
    J Clin Oncol; 2023 Jun; 41(16):3009-3018. PubMed ID: 36913642
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Primary robotic retroperitoneal lymph node dissection following orchiectomy for testicular germ cell tumors: a single-surgeon experience.
    Supron AD; Cheaib JG; Biles MJ; Schwen Z; Allaf M; Pierorazio PM
    J Robot Surg; 2021 Apr; 15(2):309-313. PubMed ID: 32572754
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Indications, feasibility and outcome of robotic retroperitoneal lymph node dissection for metastatic testicular germ cell tumours.
    Ohlmann CH; Saar M; Pierchalla LC; Zangana M; Bonaventura A; Stöckle M; Siemer S; Heinzelbecker J
    Sci Rep; 2021 May; 11(1):10700. PubMed ID: 34021196
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adverse Surgical Outcomes Associated with Robotic Retroperitoneal Lymph Node Dissection Among Patients with Testicular Cancer.
    Calaway AC; Einhorn LH; Masterson TA; Foster RS; Cary C
    Eur Urol; 2019 Nov; 76(5):607-609. PubMed ID: 31174891
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Post-chemotherapy retroperitoneal lymph node dissection in the management of metastatic testis cancer: the 16-year experience in an Irish setting.
    Considine S; Heaney R; Conroy R; Thornhill JA
    Ir J Med Sci; 2016 Nov; 185(4):901-907. PubMed ID: 26692387
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Major complications of post-chemotherapy retroperitoneal lymph node dissection in a contemporary cohort of patients with testicular cancer and a review of the literature.
    Ruf CG; Krampe S; Matthies C; Anheuser P; Nestler T; Simon J; Isbarn H; Dieckmann KP
    World J Surg Oncol; 2020 Sep; 18(1):253. PubMed ID: 32972425
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Postchemotherapy robotic retroperitoneal lymph node dissection for non-seminomatous germ cell tumors in the lateral decubitus position: oncological and functional outcomes.
    Kordan Y; Köseoğlu E; Esen B; Özkan A; Kiremit MC; Kılıç M; Esen T
    World J Urol; 2023 Apr; 41(4):1101-1107. PubMed ID: 36806014
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Laparoscopic Retroperitoneal Lymph Node Dissection as a Safe Procedure for Postchemotherapy Residual Mass in Testicular Cancer.
    Faria EF; Neves HS; Dauster B; Machado RD; Magnabosco WJ; Muller RL; Santos AC; Tobias-Machado M
    J Laparoendosc Adv Surg Tech A; 2018 Feb; 28(2):168-173. PubMed ID: 29215949
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Therapeutic supine robotic retroperitoneal lymph node dissection for post-chemotherapy residual masses in testicular cancer: technique and outcome analysis of initial experience.
    Tamhankar AS; Patil SR; Ojha SP; Ahluwalia P; Gautam G
    J Robot Surg; 2019 Dec; 13(6):747-756. PubMed ID: 30656537
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Randomized phase III trial comparing retroperitoneal lymph node dissection with one course of bleomycin and etoposide plus cisplatin chemotherapy in the adjuvant treatment of clinical stage I Nonseminomatous testicular germ cell tumors: AUO trial AH 01/94 by the German Testicular Cancer Study Group.
    Albers P; Siener R; Krege S; Schmelz HU; Dieckmann KP; Heidenreich A; Kwasny P; Pechoel M; Lehmann J; Kliesch S; Köhrmann KU; Fimmers R; Weissbach L; Loy V; Wittekind C; Hartmann M;
    J Clin Oncol; 2008 Jun; 26(18):2966-72. PubMed ID: 18458040
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Morbidity of open retroperitoneal lymph node dissection for testicular cancer: contemporary perioperative data.
    Williams SB; McDermott DW; Winston D; Bahnson E; Berry AM; Steele GS; Richie JP
    BJU Int; 2010 Apr; 105(7):918-21. PubMed ID: 19747353
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Minimally invasive post-chemotherapy retroperitoneal lymph node dissection for nonseminoma.
    Sharma P; Sverrisson EF; Zargar-Shoshtari K; Fishman MN; Sexton WJ; Dickinson SI; Spiess PE; Poch MA; Gilbert SM; Pow-Sang JM
    Can J Urol; 2015 Aug; 22(4):7882-9. PubMed ID: 26267026
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Postchemotherapy retroperitoneal lymph node dissection in advanced testicular cancer: radical or modified template resection.
    Heidenreich A; Pfister D; Witthuhn R; Thüer D; Albers P
    Eur Urol; 2009 Jan; 55(1):217-24. PubMed ID: 18926622
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Retroperitoneal lymph node dissection as adjuvant therapy in the treatment of non-seminomatous testicular cancer.
    Thijssens K; Vaneerdeweg W; Schrijvers D; Eyskens E; Van Oosterom A
    Acta Chir Belg; 2003; 103(6):599-602. PubMed ID: 14743567
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Robot-assisted retroperitoneal lymph node dissection: technique and initial case series of 18 patients.
    Cheney SM; Andrews PE; Leibovich BC; Castle EP
    BJU Int; 2015 Jan; 115(1):114-20. PubMed ID: 24825773
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Robot-assisted retroperitoneal lymph node dissection (RA-RPLND) in the adolescent population.
    Glaser AP; Bowen DK; Lindgren BW; Meeks JJ
    J Pediatr Urol; 2017 Apr; 13(2):223-224. PubMed ID: 28262537
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Primary and Postchemotherapy Retroperitoneal Lymphadenectomy for Testicular Cancer.
    Heidenreich A; Paffenholz P; Nestler T; Pfister D
    Oncol Res Treat; 2018; 41(6):370-378. PubMed ID: 29772568
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Extraperitoneal laparoscopic retroperitoneal lymph node dissection after chemotherapy for nonseminomatous testicular germ-cell tumor: surgical and oncological outcomes.
    Arai Y; Kaiho Y; Yamada S; Saito H; Mitsuzuka K; Yamashita S; Namiki S; Nakagawa H; Ishidoya S; Ito A
    Int Urol Nephrol; 2012 Oct; 44(5):1389-95. PubMed ID: 22648291
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.